Dense Breasts on Your Mammogram Letter: What to Ask Next

Since September 10, 2024, federal rules have required every certified mammography facility to tell you in writing whether your breast tissue is dense. You're far from alone: 43.3% of US women ages 40 to 74 have dense breasts, according to a national estimate built from more than 1.5 million mammograms and published in the Journal of the National Cancer Institute.

Your letter carries two separate pieces of information. Federal rules require the mammography report to give an overall result, such as Negative, Benign or Probably Benign, and, as its own item, an assessment of breast density. A dense reading doesn't turn a negative result into something else.

If the letter asks you to come back for more pictures, that's a callback, and it's a different matter from density. Schedule it quickly. Our guide to the breast cancer follow-up gap explains why the days after an abnormal screen matter.

The facility has to send your plain-language summary within 30 calendar days of the exam, or within 7 calendar days of the final reading when the result is Suspicious or Highly Suggestive of Malignancy. If you haven't heard anything, call and ask.

The FDA wrote the core wording itself. If your tissue is dense, your summary must include this statement:

"Breast tissue can be either dense or not dense. Dense tissue makes it harder to find breast cancer on a mammogram and also raises the risk of developing breast cancer. Your breast tissue is dense. In some people with dense tissue, other imaging tests in addition to a mammogram may help find cancers. Talk to your healthcare provider about breast density, risks for breast cancer, and your individual situation."

If your tissue is not dense, the letter says so and still tells you to talk with your provider about density and risk.

Your letter says only dense or not dense. The full report that goes to your clinician uses one of four categories, and federal regulation sets the exact words:

• "The breasts are almost entirely fatty." Your letter says not dense.
• "There are scattered areas of fibroglandular density." Your letter says not dense.
• "The breasts are heterogeneously dense, which may obscure small masses." Your letter says dense.
• "The breasts are extremely dense, which lowers the sensitivity of mammography." Your letter says dense.

The category is the radiologist's read of how much of your breast shows up as fibrous and glandular tissue on the images. In the national estimate above, the share of women in the two dense categories fell as age rose.

Density is a visual judgment, and radiologists differ. In a study of 83 radiologists at 30 US facilities, the share of mammograms each one called dense ranged from 6.3% to 84.5%. Among women whose back-to-back mammograms were read by different radiologists, 17.2% were called dense one time and not dense the next, or the reverse.

So a letter that flips doesn't necessarily mean your breasts changed. Ask for your full reports and compare the category across years. Facilities must release copies of your mammograms and reports within 15 calendar days of a request, and any fee can't exceed their documented cost.

Dense tissue can mask a tumor on a mammogram. In a US registry study of screening mammograms done from 1996 to 1998, mammography caught 87.0% of cancers in women with almost entirely fatty breasts and 62.9% in women with extremely dense breasts.

Density is also a risk factor on its own. A pooled analysis of 42 studies called it one of the strongest risk factors for breast cancer, with risk climbing as the dense share of the breast grows.

Two findings keep that in proportion. In a study of 365,426 women, about half of those with dense breasts had a low or average five-year breast cancer risk, and the researchers concluded that density alone shouldn't decide who gets extra imaging. Among 9,232 women diagnosed with breast cancer, the densest category was not linked to a higher chance of dying from it once stage, treatment and other factors were accounted for.

The American College of Radiology recommends that every woman have a breast cancer risk assessment by age 25, especially Black women and women of Ashkenazi Jewish heritage. The assessment weighs your family history, genetic results, past biopsies and other factors, and the answer changes which screening makes sense.

Under the college's 2023 guidance, women with a calculated lifetime risk of 20% or more should have breast MRI screening in addition to mammograms. For women with dense breasts who want extra screening, it recommends MRI, and says contrast-enhanced mammography or ultrasound could be considered for women who qualify but can't have an MRI.

If breast or ovarian cancer runs in your family, say so plainly. The Task Force keeps a separate recommendation on risk assessment and genetic counseling for BRCA-related cancer, and our guide to triple-negative breast cancer covers BRCA testing.

Bring the questions yourself. In a national survey of 2,306 women, only 61% of those who talked with a clinician about density after a mammogram said other screening options came up. In the same survey, 85% of Black women said they preferred to learn their density from a provider rather than in writing or online.

Supplemental screening means an imaging test added after a mammogram that looked normal. The main options are MRI, contrast-enhanced mammography and ultrasound. In its 2024 review, the Task Force found no study of extra screening that reported on breast cancer deaths or other health outcomes.

MRI uses strong magnets and radio waves. The abbreviated breast MRI studied in women with dense breasts takes under 10 minutes, uses a gadolinium contrast agent given through an IV, and involves no radiation or breast compression.

In the DENSE trial in the Netherlands, 40,373 women ages 50 to 75 with extremely dense breasts and a normal mammogram were randomly assigned to an invitation for MRI or to mammograms alone. Over two years, cancers diagnosed between screenings ran 2.5 per 1,000 screenings in the MRI-invitation group and 5.0 per 1,000 in the mammogram-only group.

The price was false alarms. In the first MRI round, there were 79.8 false positives per 1,000 screenings, falling to 26.3 per 1,000 in the second round.

In a US and German study of 1,444 women with dense breasts who had both tests, abbreviated MRI found all 17 invasive cancers and 3D mammography found 7 of them.

This is a mammogram taken after an iodine-based contrast dye goes in through an IV. A 2022 review in the European Journal of Radiology describes a slightly higher radiation dose than a standard mammogram and a low risk of a reaction to the dye, and calls it less expensive and more accessible than MRI.

In the UK's BRAID trial of women ages 50 to 70 with dense breasts and a negative mammogram, contrast-enhanced mammography and abbreviated MRI each found about three times as many invasive cancers as automated whole-breast ultrasound. The contrast mammography arm recorded 24 reactions to the dye: 17 minor, 6 moderate and 1 severe.

Ultrasound uses sound waves, and the FDA notes there is no ionizing radiation involved. In the ACRIN 6666 study of 2,809 women at higher risk with dense tissue, adding one screening ultrasound found 4.2 more cancers per 1,000 women (a range of 1.1 to 7.2) and substantially increased false positives.

Results in community practice were less encouraging. In a US study that matched women screened with and without added ultrasound, cancer detection was about the same, 5.4 versus 5.5 per 1,000 screens, while false-positive biopsy rates were more than double, 52.0 versus 22.2 per 1,000.

Digital breast tomosynthesis, often called 3D mammography, is a type of mammogram rather than an added test. The Task Force calls both standard digital and 3D mammography effective screening tools.

The US Preventive Services Task Force recommends a screening mammogram every other year for women ages 40 to 74, and it says women with dense breasts should start at 40 too. For supplemental ultrasound or MRI after a normal mammogram, its April 30, 2024 final recommendation gives an I statement: the evidence is "insufficient to assess the balance of benefits and harms."

The Task Force says plainly that this is "not a recommendation for or against supplemental screening in women with dense breasts," and that women should talk with their clinicians about what is best for them. It also says it needs more evidence on whether different screening strategies would help Black women, and it has called for that research.

On December 20, 2024, the Health Resources and Services Administration (HRSA) accepted an update to the women's preventive services guidelines that most private plans must follow under the Affordable Care Act. HRSA said the update takes effect for most plans in 2026.

The guideline for women at average risk now reads, in part: "Women may require additional imaging to complete the screening process or to address findings on the initial screening mammography. If additional imaging (e.g., magnetic resonance imaging (MRI), ultrasound, mammography) and pathology evaluation are indicated, these services also are recommended to complete the screening process for malignancies." Non-grandfathered plans must cover the listed services without cost sharing.

Average risk here rules out a harmful BRCA mutation (or being the untested parent, sibling or child of a carrier), another inherited cancer syndrome, a previous high-risk breast lesion, and high-dose chest radiation between ages 10 and 30. Density is not on that list.

What the update doesn't do is create a separate rule for dense breasts. When commenters asked for dense-breast language, HRSA declined, citing no randomized trials to support separate recommendations, and said the update "supports additional testing to complete initial screening, if needed, which may be more common for women with dense breasts."

So before you book an MRI or ultrasound ordered because of density after a normal mammogram, ask your plan in writing whether it will cover the exam as preventive, with no cost sharing, under HRSA's women's preventive services guidelines. If a bill arrives, ask again in writing.

Two limits apply. Grandfathered plans are exempt. And because the Task Force rated supplemental screening an I rather than an A or B, its recommendation doesn't by itself require coverage of the extra test.

Some states go further for the plans they regulate. Washington bars cost sharing for supplemental and diagnostic breast exams, including MRI and ultrasound, in non-grandfathered plans issued or renewed on or after January 1, 2024 that cover those exams, with a narrow exception for plans paired with a health savings account.

State insurance laws generally don't apply to self-insured employer plans, according to the US Department of Labor. Ask your HR office which kind of plan you have.

Medicare runs on its own rules. Part B covers a screening mammogram once every 12 months, and you pay nothing when the provider accepts assignment. Diagnostic mammograms cost 20% of the Medicare-approved amount after the Part B deductible, and Medicare says it "only covers medically necessary breast ultrasounds when your health care provider orders them."

No insurance? Our guides to free mammograms and free mammograms without insurance walk through the CDC screening program, which also funds diagnostic services, and our breast cancer screening finder lists free and low-cost sites city by city.

The Find It Early Act would provide coverage with no cost sharing for additional breast screenings for people at greater risk of breast cancer. It was introduced in the Senate in April 2025 and in the House in November 2025. As of mid-September 2026, both versions were still in committee, so nothing in it is law.

• Which of the four density categories is on my full report, and can I have a copy?
• What is my estimated breast cancer risk, and what did you base it on?
• With my risk and my density, would an extra test help me? Which one, and why that one?
• How often does that test lead to a callback or a biopsy that turns out to be nothing?
• Will my plan cover it as preventive screening with no cost sharing? Can you help me get that answer in writing?
• If this facility doesn't offer MRI or contrast-enhanced mammography, where can I get it?
• When should my next mammogram be?

If you want a clinician who will walk through your risk and your options with you, search our directory of Black providers. Bring your full mammogram report, your family history, and the questions above.